(Q43668225)

25 November 2017

title

Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia (English)

1 reference

25 November 2017

0 references

0 references

Savaskan E

1

1 reference

25 November 2017

Hock C

2

1 reference

25 November 2017

Olivieri G

3

1 reference

25 November 2017

Bruttel S

4

1 reference

25 November 2017

Rosenberg C

5

1 reference

25 November 2017

Hulette C

6

1 reference

25 November 2017

Müller-Spahn F

7

1 reference

25 November 2017

publication date

1 July 2001

1 reference

25 November 2017

published in

Neurobiology of Aging

1 reference

25 November 2017

volume

22

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

541-546

1 reference

Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical Areas

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Neuropeptide abnormalities in patients with early Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Angiotensin II receptor subtypes in the human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Vascular nitric oxide may lessen Alzheimer's risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Fos induced in brain of spontaneously hypertensive rats by angiotensin II and co-localization with AT-1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Cerebral Blood Flow in White Matter Is Correlated with Systolic Blood Pressure and EEG in Senile Dementia of the Alzheimer Type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

The relationship between blood pressure and dementia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

A review on blood pressure and ischaemic white matter lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Important roles for angiotensin III and IV in the brain renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2800%2900259-1

7 January 2021

10.1016/S0197-4580(00)00259-1

Identifiers

DOI

1 reference

25 November 2017

1 reference